Product Code: CHFR
TABLE OF CONTENTS
List Of Contents And Tables
EXECUTIVE SUMMARY
Consumer health in 2021: The big picture
2021 key trends
Competitive landscape
Retailing developments
What next for consumer health?
MARKET INDICATORS
Table 1 Consumer Expenditure on Health Goods and Medical Services: Value 2016-2021
Table 2 Life Expectancy at Birth 2016-2021
MARKET DATA
Table 3 Sales of Consumer Health by Category: Value 2016-2021
Table 4 Sales of Consumer Health by Category: % Value Growth 2016-2021
Table 5 NBO Company Shares of Consumer Health: % Value 2017-2021
Table 6 LBN Brand Shares of Consumer Health: % Value 2018-2021
Table 7 Penetration of Private Label in Consumer Health by Category: % Value 2016-2021
Table 8 Distribution of Consumer Health by Format: % Value 2016-2021
Table 9 Distribution of Consumer Health by Format and Category: % Value 2021
Table 10 Forecast Sales of Consumer Health by Category: Value 2021-2026
Table 11 Forecast Sales of Consumer Health by Category: % Value Growth 2021-2026
APPENDIX
OTC registration and classification
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventive medicine
Switches
DISCLAIMER
DEFINITIONS
SOURCES
Summary 1 Research Sources
ANALGESICS IN FRANCE
KEY DATA FINDINGS
2021 DEVELOPMENTS
Decline in demand for analgesics accelerated by shift from OTC to BTC
Efforts to slow COVID-19 transmission lead to a sharp decline in seasonal illness
The category tries to keep dynamic in terms of communication and product innovation
PROSPECTS AND OPPORTUNITIES
Efforts to educate consumers regarding the risks associated with self-medication will negatively affect demand for analgesics
Declining fertility rate will limit growth in demand for paediatric analgesics
Consumers will increasingly seek out natural alternatives to analgesics
CATEGORY DATA
Table 12 Sales of Analgesics by Category: Value 2016-2021
Table 13 Sales of Analgesics by Category: % Value Growth 2016-2021
Table 14 NBO Company Shares of Analgesics: % Value 2017-2021
Table 15 LBN Brand Shares of Analgesics: % Value 2018-2021
Table 16 Forecast Sales of Analgesics by Category: Value 2021-2026
Table 17 Forecast Sales of Analgesics by Category: % Value Growth 2021-2026
COUGH, COLD AND ALLERGY (HAY FEVER) REMEDIES IN FRANCE
KEY DATA FINDINGS
2021 DEVELOPMENTS
Measures designed to curb COVID-19 transmission lead to a subdued flu season
Warning from regulator regarding the potential risks associated with some cough medications negatively affect demand
After an unusually warm 2020, a cooler 2021 will lead to slower growth in retail current value sales of antihistamines/allergy remedies (systemic)
PROSPECTS AND OPPORTUNITIES
Measures intended to reduce the spread of COVID-19 are likely to persist
Herbal alternatives will continue to grow in popularity
Allergies will continue to become more common
CATEGORY DATA
Table 18 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2016-2021
Table 19 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2016-2021
Table 20 NBO Company Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2017-2021
Table 21 LBN Brand Shares of Cough, Cold and Allergy (Hay Fever) Remedies: % Value 2018-2021
Table 22 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2021-2026
Table 23 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2021-2026
DIGESTIVE REMEDIES IN FRANCE
KEY DATA FINDINGS
2021 DEVELOPMENTS
Reduction in incidence of gastroenteritis due to COVID-19 measures depresses demand
Lockdown weight gain boosts demand for antacids
Stress and sedentarism drive increased demand for laxatives
PROSPECTS AND OPPORTUNITIES
Growing popularity of probiotics poses a threat to digestive remedies
Long-term effect of COVID-19 on social behaviour could reduce the incidence of gastroenteritis
Increased prevalence of heartburn will continue to support growth in demand for antacids
CATEGORY DATA
Table 24 Sales of Digestive Remedies by Category: Value 2016-2021
Table 25 Sales of Digestive Remedies by Category: % Value Growth 2016-2021
Table 26 NBO Company Shares of Digestive Remedies: % Value 2017-2021
Table 27 LBN Brand Shares of Digestive Remedies: % Value 2018-2021
Table 28 Forecast Sales of Digestive Remedies by Category: Value 2021-2026
Table 29 Forecast Sales of Digestive Remedies by Category: % Value Growth 2021-2026
DERMATOLOGICALS IN FRANCE
KEY DATA FINDINGS
2021 DEVELOPMENTS
School closures impede the spread of head lice
Having seen strong growth during 2020, demand for topical germicidals/antiseptics will stabilise in 2021
Broad product portfolios help Johnson & Johnson and Bayer stay on top in a fragmented competitive landscape
PROSPECTS AND OPPORTUNITIES
Nappy rash treatments will lose ground to alternatives perceived as more natural
A greying population will drive demand growth for some types of dermatologicals
Increased socialising will boost retail current value sales of antifungals
CATEGORY DATA
Table 30 Sales of Dermatologicals by Category: Value 2016-2021
Table 31 Sales of Dermatologicals by Category: % Value Growth 2016-2021
Table 32 NBO Company Shares of Dermatologicals: % Value 2017-2021
Table 33 LBN Brand Shares of Dermatologicals: % Value 2018-2021
Table 34 LBN Brand Shares of Hair Loss Treatments: % Value 2018-2021
Table 35 Forecast Sales of Dermatologicals by Category: Value 2021-2026
Table 36 Forecast Sales of Dermatologicals by Category: % Value Growth 2021-2026
NRT SMOKING CESSATION AIDS IN FRANCE
KEY DATA FINDINGS
2021 DEVELOPMENTS
OTC demand undermined by shift to reimbursement
COVID-19 leads to a slowdown in smoking cessation efforts
Communication campaigns against smoking are intensifying
PROSPECTS AND OPPORTUNITIES
Shift away from OTC will deepen as awareness of reimbursement grows
More smokers will attempt to quit, but most of them will get prescriptions
E-cigarettes an emerging competitive threat to NRT smoking cessation aids
CATEGORY INDICATORS
Table 37 Number of Smokers by Gender 2016-2021
CATEGORY DATA
Table 38 Sales of NRT Smoking Cessation Aids by Category: Value 2016-2021
Table 39 Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2016-2021
Table 40 NBO Company Shares of NRT Smoking Cessation Aids: % Value 2017-2021
Table 41 LBN Brand Shares of NRT Smoking Cessation Aids: % Value 2018-2021
Table 42 Forecast Sales of NRT Smoking Cessation Aids by Category: Value 2021-2026
Table 43 Forecast Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2021-2026
SLEEP AIDS IN FRANCE
KEY DATA FINDINGS
2021 DEVELOPMENTS
COVID-19 lockdowns drive rise in sleep disorders
Consumers shift from sedatives to natural products
Marketing campaigns and new product launches help to maintain consumer awareness
PROSPECTS AND OPPORTUNITIES
Heightened anxiety will help to sustain strong growth in demand for sleep aids
Phytotherapy will play an increasingly important role in sleep aids
Better sleep 'hygiene' could undermine demand for sleep aids
CATEGORY DATA
Table 44 Sales of Sleep Aids: Value 2016-2021
Table 45 Sales of Sleep Aids: % Value Growth 2016-2021
Table 46 NBO Company Shares of Sleep Aids: % Value 2017-2021
Table 47 LBN Brand Shares of Sleep Aids: % Value 2018-2021
Table 48 Forecast Sales of Sleep Aids: Value 2021-2026
Table 49 Forecast Sales of Sleep Aids: % Value Growth 2021-2026
EYE CARE IN FRANCE
KEY DATA FINDINGS
2021 DEVELOPMENTS
Bad pollen season boosts demand for allergy eye during 2020, but 2021 will be less favourable
Increased screen time leads to increased demand for standard eye care
Pharmacies remain the dominant distribution channel for standard eye care
PROSPECTS AND OPPORTUNITIES
Global warming, an ageing population and high levels of screen use will continue to support robust demand growth for eye care
Remote work will boost demand for standard eye care
More screen time for children will increase the prevalence of visual problems
CATEGORY DATA
Table 50 Sales of Eye Care by Category: Value 2016-2021
Table 51 Sales of Eye Care by Category: % Value Growth 2016-2021
Table 52 NBO Company Shares of Eye Care: % Value 2017-2021
Table 53 LBN Brand Shares of Eye Care: % Value 2018-2021
Table 54 Forecast Sales of Eye Care by Category: Value 2021-2026
Table 55 Forecast Sales of Eye Care by Category: % Value Growth 2021-2026
WOUND CARE IN FRANCE
KEY DATA FINDINGS
2021 DEVELOPMENTS
Lockdowns undermine demand for wound care
Lack of international tourists an additional negative factor
Laboratoires Mercurochrome launches sticking plasters made from bamboo fibre
PROSPECTS AND OPPORTUNITIES
Revival in outdoor activities and international tourism will drive recovery
An ageing population will underpin retail current value sales growth
Hypermarkets, supermarkets and e-commerce represent a growing competitive threat to chemists/pharmacies
CATEGORY DATA
Table 56 Sales of Wound Care by Category: Value 2016-2021
Table 57 Sales of Wound Care by Category: % Value Growth 2016-2021
Table 58 NBO Company Shares of Wound Care: % Value 2017-2021
Table 59 LBN Brand Shares of Wound Care: % Value 2018-2021
Table 60 Forecast Sales of Wound Care by Category: Value 2021-2026
Table 61 Forecast Sales of Wound Care by Category: % Value Growth 2021-2026
VITAMINS IN FRANCE
KEY DATA FINDINGS
2021 DEVELOPMENTS
COVID-19 drives sharp acceleration in retail current value sales growth
Vitamins explosion for both adults and children populations
Pharmacies seek to boost impulse purchasing
PROSPECTS AND OPPORTUNITIES
Retail current value sales growth will slow, but the pandemic has served to reinforce the importance health and wellness to local consumers
Personalised vitamins could appeal to young adults with hectic lifestyles
Healthier diets could pose a threat to demand for vitamins
CATEGORY DATA
Table 62 Sales of Vitamins by Category: Value 2016-2021
Table 63 Sales of Vitamins by Category: % Value Growth 2016-2021
Table 64 Sales of Multivitamins by Positioning: % Value 2016-2021
Table 65 NBO Company Shares of Vitamins: % Value 2017-2021
Table 66 LBN Brand Shares of Vitamins: % Value 2018-2021
Table 67 Forecast Sales of Vitamins by Category: Value 2021-2026
Table 68 Forecast Sales of Vitamins by Category: % Value Growth 2021-2026
DIETARY SUPPLEMENTS IN FRANCE
KEY DATA FINDINGS
2021 DEVELOPMENTS
Pandemic restrictions undermine demand for dietary supplements
Demand for probiotics adversely affected by fall in gastroenteritis cases
COVID-19 boosts consumer interest in Merck's Bion immune system supplement
PROSPECTS AND OPPORTUNITIES
For a growing number of local consumers, prevention is better than cure
Go with your gut
Organic ingredients set to grow in importance as a point of differentiation
CATEGORY DATA
Table 69 Sales of Dietary Supplements by Category: Value 2016-2021
Table 70 Sales of Dietary Supplements by Category: % Value Growth 2016-2021
Table 71 Sales of Dietary Supplements by Positioning: % Value 2016-2021
Table 72 NBO Company Shares of Dietary Supplements: % Value 2017-2021
Table 73 LBN Brand Shares of Dietary Supplements: % Value 2018-2021
Table 74 Forecast Sales of Dietary Supplements by Category: Value 2021-2026
Table 75 Forecast Sales of Dietary Supplements by Category: % Value Growth 2021-2026
WEIGHT MANAGEMENT AND WELLBEING IN FRANCE
KEY DATA FINDINGS
2021 DEVELOPMENTS
Lockdown gives consumers more time to prepare nutritious meals, dampening demand for meal replacement and weight loss supplements
Wide distribution helps Gerlinea maintain a strong leadership position in meal replacement plans
Working from home boosts demand for hot drinks, including slimming teas
PROSPECTS AND OPPORTUNITIES
With many local consumers adopting a more holistic approach to dieting, demand growth for meal replacement and weight loss supplements will be anaemic
Personal advice will grow in importance
If it's not hurting, it's not working
CATEGORY DATA
Table 76 Sales of Weight Management and Wellbeing by Category: Value 2016-2021
Table 77 Sales of Weight Management and Wellbeing by Category: % Value Growth 2016-2021
Table 78 NBO Company Shares of Weight Management and Wellbeing: % Value 2017-2021
Table 79 LBN Brand Shares of Weight Management and Wellbeing: % Value 2018-2021
Table 80 Forecast Sales of Weight Management and Wellbeing by Category: Value 2021-2026
Table 81 Forecast Sales of Weight Management and Wellbeing by Category: % Value Growth 2021-2026
SPORTS NUTRITION IN FRANCE
KEY DATA FINDINGS
2021 DEVELOPMENTS
Easing of COVID-19 restrictions will drive a modest rebound in demand for sports nutrition
Consumers are increasingly mixing and matching sports nutrition and weight management and wellbeing offerings
More sophisticated and specialised brands tend to focus on organic and natural products
PROSPECTS AND OPPORTUNITIES
COVID-29 will boost growth by heightening consumer awareness of the importance of exercise and the health risks associated with obesity
Importance of professional advice will help to keep specialist retailers on top
The line between sports nutrition and dietary supplements are blurring
CATEGORY DATA
Table 82 Sales of Sports Nutrition by Category: Value 2016-2021
Table 83 Sales of Sports Nutrition by Category: % Value Growth 2016-2021
Table 84 NBO Company Shares of Sports Nutrition: % Value 2017-2021
Table 85 LBN Brand Shares of Sports Nutrition: % Value 2018-2021
Table 86 Forecast Sales of Sports Nutrition by Category: Value 2021-2026
Table 87 Forecast Sales of Sports Nutrition by Category: % Value Growth 2021-2026
HERBAL/TRADITIONAL PRODUCTS IN FRANCE
KEY DATA FINDINGS
2021 DEVELOPMENTS
Demand for herbal/traditional products boosted by increased consumer interest in natural products
COVID-19 disruption boosts demand for herbal/traditional sleep aids
Launch of natural vitamins helps Laboratoires Arkopharma retain its leadership
PROSPECTS AND OPPORTUNITIES
Strong growth will lead to increased competition among manufacturers
Emerging natural alternatives will increasingly compete with herbal/traditional products
Now that CBD has belatedly been legalised, it is likely to see strong growth in demand
CATEGORY DATA
Table 88 Sales of Herbal/Traditional Products by Category: Value 2016-2021
Table 89 Sales of Herbal/Traditional Products by Category: % Value Growth 2016-2021
Table 90 NBO Company Shares of Herbal/Traditional Products: % Value 2017-2021
Table 91 LBN Brand Shares of Herbal/Traditional Products: % Value 2018-2021
Table 92 Forecast Sales of Herbal/Traditional Products by Category: Value 2021-2026
Table 93 Forecast Sales of Herbal/Traditional Products by Category: % Value Growth 2021-2026
PAEDIATRIC CONSUMER HEALTH IN FRANCE
KEY DATA FINDINGS
2021 DEVELOPMENTS
Paediatric cough and cold remedies fall out of favour
COVID-19 boosts demand for paediatric vitamins and dietary supplements
Nappy (diaper) rash treatments lose because they are perceived as 'un-natural'
PROSPECTS AND OPPORTUNITIES
A declining fertility rate will weigh on retail current value sales growth
Natural remedies will continue to grow in popularity as an alternative to NSAIDs and cough and cold remedies
Product offer in paediatric vitamins and dietary supplements is expected to widen
CATEGORY DATA
Table 94 Sales of Paediatric Consumer Health by Category: Value 2016-2021
Table 95 Sales of Paediatric Consumer Health by Category: % Value Growth 2016-2021
Table 96 Sales of Paediatric Vitamins and Dietary Supplements by Type: % Value 2016-2021
Table 97 NBO Company Shares of Paediatric Consumer Health: % Value 2017-2021
Table 98 LBN Brand Shares of Paediatric Consumer Health: % Value 2018-2021
Table 99 Forecast Sales of Paediatric Consumer Health by Category: Value 2021-2026
Table 100 Forecast Sales of Paediatric Consumer Health by Category: % Value Growth 2021-2026
